Mallinckrodt announces plan for new N.J. campus

CHESTERFIELD, U.K. — Mallinckrodt announced Thursday that it would be building a new campus for its specialty brands organization in Bedminster, N.J.’s Somerset Financial Center. The company will invest more than $80 million in New Jersey, and expects that some 400 employees will occupy the new space in the first quarter of 2017. The new location will consolidate the operations for its specialty brands groups.

 

“As we began to transform Mallinckrodt into a specialty pharmaceutical organization, we acquired a base of established operations on the East Coast,” Mallinckrodt president and CEO Mark Trudeau said. “With this base, and recognizing the important concentration of specialty pharmaceutical talent and intellectual capital in the area, we believe consolidating our Specialty Brands organizations in New Jersey provides compelling value. We believe the state will be a great business destination for the company.”

 

In addition to its planned New Jersey investment, the company is continuing to invest in St. Louis, Mo., having recently started the next phase of construction on its manufacturing facility there. The construction is part of the more than $140 million in capital projects and relates expenses Mallinckrodt has invested in the buildings that house its legacy businesses and key administrative functions there, which included $12 million for a sire opened in mid-2015 to increase manufacturing efficiency. 

 

“For decades, Mallinckrodt has proudly maintained a significant presence in St. Louis, where many of us continue to live and work, and we're excited to reinforce that presence in this region with continued reinvestment,” Trudeau said.